These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12260)

  • 1. Methods for study of fluphenazine kinetics in man.
    Whelpton R; Curry SH
    J Pharm Pharmacol; 1976 Dec; 28(12):869-73. PubMed ID: 12260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.
    Curry SH; Whelpton R; de Schepper PJ; Vranckx S; Schiff AA
    Br J Clin Pharmacol; 1979 Apr; 7(4):325-31. PubMed ID: 444352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.
    Dreyfuss J; Shaw JM; Ross JJ
    J Pharm Sci; 1976 Sep; 65(9):1310-5. PubMed ID: 966144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excretion and biotransformation of the enanthate ester of fluphenazine- 14 C by the dog.
    Dreyfuss J; Ross JJ; Schreiber EC
    J Pharm Sci; 1971 Jun; 60(6):829-33. PubMed ID: 5128931
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine.
    Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Midha KK
    Ther Drug Monit; 1994 Feb; 16(1):21-9. PubMed ID: 8160250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of oral fluphenazine disposition in humans by GC-MS.
    Midha KK; McKay G; Edom R; Korchinski ED; Hawes EM; Hall K
    Eur J Clin Pharmacol; 1983; 25(5):709-11. PubMed ID: 6662169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugates.
    Jackson CJ; Hubbard JW; McKay G; Cooper JK; Hawes EM; Midha KK
    Drug Metab Dispos; 1991; 19(1):188-93. PubMed ID: 1673397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic monitoring of steady-state plasma levels of the N4'-oxide metabolite of fluphenazine in chronically treated schizophrenic patients determined by a specific and sensitive radioimmunoassay.
    Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Hubbard JW; Midha KK
    Ther Drug Monit; 1990 May; 12(3):268-76. PubMed ID: 2349611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release and elimination of 14C-fluphenazine enanthate and decanoate esters administered in sesame oil to dogs.
    Dreyfuss J; Ross JJ; Shaw JM; Miller I; Schreiber EC
    J Pharm Sci; 1976 Apr; 65(4):502-507. PubMed ID: 1271246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly sensitive and specific radioimmunoassay for quantitation of plasma fluphenazine.
    Lo ES; Fein M; Hunter C; Suckow RF; Cooper TB
    J Pharm Sci; 1988 Mar; 77(3):255-8. PubMed ID: 3373431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of the depot antipsychotics.
    Jann MW; Ereshefsky L; Saklad SR
    Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal model for investigation of fluphenazine kinetics after administration of long-acting esters.
    Altamura AC; Whelpton R; Curry SH
    Biopharm Drug Dispos; 1979; 1(2):65-72. PubMed ID: 552863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive gas-chromatographic determination of fluphenazine in human plasma.
    Franklin M; Wiles DH; Harvey DJ
    Clin Chem; 1978 Jan; 24(1):41-4. PubMed ID: 618664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low neuroleptic serum levels in patients receiving fluphenazine decanoate.
    Tune LE; Creese I; Coyle JT; Pearlson G; Snyder SH
    Am J Psychiatry; 1980 Jan; 137(1):80-2. PubMed ID: 6101523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
    Jouen F; Verité P; André D; Colonna L; Boucly P
    Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.
    Adamson L; Curry SH; Bridges PK; Firestone AF; Lavin NI; Lewis DM; Watson RD; Xavier CM; Anderson JA
    Dis Nerv Syst; 1973; 34(4):181-91. PubMed ID: 4711886
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of 7-hydroxyfluphenazine as major metabolite of fluphenazine- 14 C in the dog.
    Dreyfuss J; Cohen AI
    J Pharm Sci; 1971 Jun; 60(6):826-8. PubMed ID: 5128930
    [No Abstract]   [Full Text] [Related]  

  • 18. Biosynthesis and characterization of glucuronide metabolites of fluphenazine: 7-hydroxyfluphenazine glucuronide and fluphenazine glucuronide.
    Jackson CJ; Hubbard JW; Midha KK
    Xenobiotica; 1991 Mar; 21(3):383-93. PubMed ID: 1907421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate.
    Marder SR; Hubbard JW; Van Putten T; Hawes EM; McKay G; Mintz J; May PR; Midha KK
    Psychopharmacol Bull; 1986; 22(1):264-6. PubMed ID: 3726072
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluphenazine determination in human plasma by a sensitive gas chromatographic method using nitrogen detector.
    Javaid JI; Dekirmenjian H; Liskevych U; Lin RL; Davis JM
    J Chromatogr Sci; 1981 Sep; 19(9):439-43. PubMed ID: 7298790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.